Document:

Employment Agreement

 Exhibit 10.8 
 UBIQUITI NETWORKS, INC. /JESSICA ZHOU 
 EXECUTIVE EMPLOYMENT AGREEMENT

 This Executive Employment Agreement (“the Agreement”) is entered into between Jessica Zhou, an individual
(“Executive”), and Ubiquiti Networks, Inc., (“the Company”), effective March 19, 2012 (the “Effective Date”). 
 1.        Position. 
 Executive
will continue to be employed as the General Counsel and Vice President of Legal Affairs (the “Position”) of the Company, reporting to the Company’s Chief Executive Officer. Executive and the Company may mutually agree to change
Executive’s positions or titles, and may from time to time alter the duties, responsibilities or functions initially associated with the positions. 
 2.        Primary Duties. 

Executive will perform such duties and functions as are generally associated with the Position as well as such other specific duties and
functions that are reasonably assigned to her from time to time by the Company’s Chief Executive Officer and the Board of Directors. 
 3.        Base Salary. 
 Beginning
on the Effective Date, Executive will receive an annual base salary of $330,000 (the “Base Salary”) which will be paid in accordance with the Company’s regular payroll practices, and which will be subject to withholding required by
law. Thereafter, Executive’s annual base salary will be reviewed at least annually to determine whether, in the sole discretion of the Compensation Committee of the Board of Directors of the Company (the “Compensation Committee”),
Executive’s base salary should be changed. 
 4.        Annual Bonus.

 Beginning in the fiscal year ending June 30, 2012, Executive will be eligible to receive an annual bonus with a target
payout equal to 35% of the Base Salary (the “Target Bonus”), subject to achieving Company and individual performance goals established by the Compensation Committee in consultation with the Executive. The award and payment of the executive
bonus will be governed by the terms of the Company’s management bonus plan as approved by the Compensation Committee, who shall have the sole discretion to determine whether Executive is entitled to any such bonus and to determine the amount of
any such bonus. Such bonus will be pro-rated for partial year of service. 

5.        Equity. 

Executive shall be granted restricted stock (the “Restricted Stock Award”) covering 50,000 shares vesting as to 25% of the
covered shares on each anniversary of the Effective Date, so as to be 100% vested on the fourth anniversary of the Effective Date, subject to Executive’s continuing as a 

 Service Provider, as such term is defined in the Plan, through each vesting date, and further subject to
accelerated vesting as set forth in Section 9 below. The Restricted Stock Award shall otherwise be subject to the terms and conditions of the Plan and the standard form of restricted stock purchase agreement thereunder. Executive shall be
eligible to participate in the Company’s equity incentive plans as such plans are applicable to executive officers of the Company. 
 6.        Executive Benefits. 

Executive will be eligible to participate in any employee benefit plans or programs, including but not limited to group medical benefits
and 401(k) plan maintained or established by the Company to the same extent as other employees at Executive’s level within the Company, subject to the generally applicable terms and conditions of the plan or program in question and the
determination of any person or committee administering such plan or program. Executive will be entitled to four weeks of vacation per year. 
 7.        Other Obligations. 

Executive will be subject to and agrees to materially adhere to all policies or procedures of the Company, as amended from time to time,
applicable to Executive’s position or level within the Company. Executive’s employment agreement is conditioned upon Executive’s executing and faithful observance of the Company’s At-Will Employment, Confidential Information,
Invention Assignment and Arbitration Agreement (the “Confidential Information Agreement”). 

8.        At-Will Employment. 

Executive’s employment with the Company is for no specified duration and is at-will. Either Executive or the Company may terminate
Executive’s employment or the terms of her employment at any time and for any reason, with or without cause and with or without notice. The at-will nature of Executive’s employment with the Company may be altered only in writing expressly
so stating signed by the Company’s Chief Executive Officer. However, as described in Section 9 of this Agreement, Executive may be entitled to severance benefits depending upon the circumstances of the termination of Executive’s
employment. 
 9.        Termination of Employment. 

(a)        Termination Not In Connection With Change of Control 

(i)        If before or more than twenty-four (24) months following a Change of Control (as
defined in Section 9(g)), the Company terminates Executive’s employment without Cause (as defined in Section 9(d)), or Executive terminates her employment for Good Reason (as defined in Section 9(f)), then, subject to Executive
entering into and not revoking a Release of Claims in substantially the form attached hereto as Exhibit A (the “Release”), the Executive shall be entitled to the following: (A) continued payments for twelve (12) months of
her then-existing Base Salary and Target Bonus, (B) Executive’s equity compensation awards shall immediately accelerate vesting as to an additional twelve (12) months, and (C) continued health and life insurance benefits (and if
applicable, to Executive’s dependents who received benefits under her coverage prior to the termination) until the earlier of (i) the end of the 12-month period following termination or (ii) the

 
date Executive becomes eligible for such benefits in connection with new employment. Any stock options or stock appreciation rights shall remain exercisable for the period prescribed in the
Executive’s stock option or stock appreciation right agreements. 
 (ii)        If
Executive’s employment is terminated with Cause or if Executive initiates the termination of her employment other than for Good Reason, Executive shall not be entitled to the severance benefits set forth above, although the Company may pay
severance in its sole discretion. 
 (b)        Termination in Connection With Change
of Control. If within the twenty-four (24) month period on or following a Change of Control (as defined in section 9(g)), Executive’s employment with the Company is terminated by the Company Without Cause or is voluntarily terminated
by Executive for Good Reason, then, subject to Executive entering into and not revoking a Release, the Executive shall be entitled to the following: (A) a lump-sum cash payment equal to twelve (12) months of her then-existing Base
Salary and Target Bonus, (B) Executive’s equity compensation awards shall immediately accelerate vesting one hundred percent (100%). And (C) continued health and life insurance benefits until the earlier of (i) the end of the
12-month period following termination (and if applicable, to Executive’s dependents who received benefits under her coverage prior to her termination) or (ii) the date Executive becomes eligible for such benefits in connection with new
employment. Any stock options or stock appreciation rights shall remain exercisable for the period prescribed in the Executive’s stock option or stock appreciation right agreements. Notwithstanding the foregoing, if the termination occurs after
the Company has entered into Change of Control discussion but before the actual consummation of the Change of Control transaction, then such termination shall be treated as a “Termination In Connection with Change of Control” within the
meaning of this section. 
 (c)        Voluntary Terminations. If executive
voluntarily terminates her employment with the Company, other than a voluntary termination for Good Reason (as defined in section 9(f)) on or within twenty-four months following a Change of Control, then Executive will (i) receive her Base
Salary through the date of termination of employment and other earned but unpaid compensation and benefits, and (ii) not be entitled to any other compensation or benefits (including, without limitation, accelerated vesting of stock options or
other equity compensation awards) from the Company except as may be required by law (for example, “COBRA” coverage under Section 4980B of the Code). All payments and benefits will be subject to applicable withholding taxes.

 (d)        Cause. For all purposes under this Agreement, a termination for
“Cause” shall mean that the Executive’s employment is terminated for any of the following reasons: (i) the Executive’s willful act of fraud, embezzlement, or dishonesty or other misconduct that has caused material harm to
the Company; (ii) the Executive’s willful failure to perform her duties to the Company, failure to materially follow Company policy as set forth in writing from time to time, or failure to follow the legal directives of the Company (other
than failure to meet performance goals, objectives or measures), that, with respect to curable failures only, is not corrected within thirty (30) days following written notice thereof to the Executive by the Company’s Chief Executive
Officer, such notice to state with specificity the nature of the failure; (iii) the Executive’s misappropriation of any material asset of the Company; (iv) the Executive conviction of, or a plea of “Guilty” or “No

 
Contest” to a felony; (v) Executive’s use of alcohol or drugs so as to interfere with the performance of her duties; (vi) the Executive’s material breach of this
Agreement or the Confidential Information Agreement that, with respect to curable failures only, is not corrected within thirty (30) days following written notice thereof to the Executive by the Company’s Chief Executive Officer, such
notice to state with specificity the nature of the material breach; (vii) conduct which is a material violation of Executive’s fiduciary obligations to the Company that is not corrected within (30) days following written notice
thereof to Executive by the Company’s Chief Executive Officer; or (viii) intentional material damage to any property of the Company. 
 (e)        Without Cause. For all purposes under this Agreement, a termination of the Employment by the Company “Without Cause” shall mean a
termination by the Company in the absence of “Cause”, as defined above. 

(f)        Good Reason. For all purposes under this Agreement, “Good Reason” for
the Executive’s resignation will exist if she resigned from her employment, unless otherwise agreed to in writing or by e-mail by the Executive, within 60 days after the occurrence of any of the following: (i) any reduction in her Base
Salary or Target Bonus (other than temporary reductions applying and comparable to all senior executives of the Company); (ii) a change in her position or title with the Company or successor company that reduces her duties and responsibilities;
(iv) office relocation of more 50 miles further from the Executive’s primary residence; or (v) any other material breach by the Company of its obligations to the Executive under this Agreement that, to the extent curable, is not
corrected within thirty (30) days following written notice thereof to the Company by the Executive, such notice to state with specificity the nature of the material breach. 

(g)        Change of Control. For purposes of this Agreement, a “Change of
Control” means the occurrence of any of the following events: 
 (i)        Any
“person” (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended) that is not a stockholder of the Company as of the date hereof becomes the “beneficial owner” (as defined under said
Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company’s then outstanding voting securities; or 

(ii)        A change in the composition of the Board of Directors of the Company occurring
within a two-year period, as a result of which fewer than a majority of the directors are Incumbent Directors. “Incumbent Directors” shall mean directors who either (a) are directors of the Company as of the date hereof, or
(b) are elected, or nominated for election, to the Board of Directors of the Company with the affirmative votes of at least a majority of the Incumbent directors at the time of such election or nomination (but shall not include an individual
whose election or nomination is in connection with an actual or threatened proxy contest relating to the election of directors to the Company); or 
 (iii)        A merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities
of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) at least fifty percent (50%) of the total

 
voting power represented by the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation. 

(h)        Death or Disability. If Executive’s employment is terminated by reason of
Executive’s death or disability, Executive shall be entitled to (1) earned but unpaid base salary, target bonus and benefits through the date of termination, (2) pro-rated acceleration of Executive’s equity awards as if such
awards had vested on a monthly basis through the date of termination, (3) any business expenses that are reimbursable pursuant to Company policy but have not been reimbursed by the Company through the date of termination, and (4) all other
applicable benefits. 
 10.        Non-Solicitation. 

During the Executive’s Employment Term, Executive, directly or indirectly, whether as an employee, owner, sole proprietor, partner,
director, member, consultant, agent, founder, co-venture or otherwise, will not engage, participate or invest in any business activity anywhere in the world which develops, manufactures or markets products or performs services which are competitive
with the products or services of the Company or products or services which the Company has under development or which are the subject of active planning. Executive is not prohibited from purchasing equities or derivatives in any publicly traded any
company. 
 For a period of twelve (12) months following the date Executive ceases to be employed by the Company for any
reason, Executive, directly or indirectly, will not: (i) solicit, induce, influence or encourage any person to leave employment with the Company or its resellers or distributors or (ii) solicit any of the Company’s customers or users
who were customers or users at any time during Executive’s employment with Company or (iii) harass or disparage the Company or its employees, clients, directors or agents. 

11.        Section 409A. 

(a)        Notwithstanding anything to the contrary in this Agreement, no Deferred Compensation
Separation Benefits payable under this Agreement will be considered due or payable until and unless Executive has a “separation from service” within the meaning of Section 409A of the U.S. Internal Revenue Code of 1986, as amended
(the “Code”) and the final regulations and any guidance promulgated under Section 409A, as each may be amended from time to time (together, “Section 409A”). Notwithstanding anything to the contrary in this Agreement, if
Executive is a “specified employee” within the meaning of Section 409A at the time of Executive’s “separation from service” other than due to Executive’s death, then any severance benefits payable pursuant to this
Agreement and any other severance payments or separation benefits, that in each case when considered together may be considered deferred compensation under Section 409A (together, the “Deferred Compensation Separation Benefits”) and
are otherwise due to Executive on or within the six (6) month period following Executive’s “separation from service” will accrue during such six (6) month period and will instead become payable in a lump sum payment on the
date six (6) months and one (1) day following the date of Executive’s “separation from service.” All subsequent Deferred Compensation Separation Benefits, if any, will be payable in accordance with the payment schedule
applicable to each payment or benefit. Each payment and benefit payable under this 

 
Agreement is intended to constitute separate payments for purposes of Section 1.409A-2(b)(2) of the Treasury Regulations. 

(b)        Notwithstanding anything herein to the contrary, if Executive dies following her
“separation from service” but prior to the six (6) month anniversary of the date of her “separation from service,” then any Deferred Compensation Separation Benefits delayed in accordance with this Section will be payable in
a lump sum as soon as administratively practicable after the date of Executive’s death, but not later than ninety (90) days after the date of Executive’s death, and all other Deferred Compensation Separation Benefits will be payable
in accordance with the payment schedule applicable to each payment or benefit. 

(c)        It is the intent of this Agreement to comply with the requirements of
Section 409A so that none of the severance payments and benefits to be provided under this Agreement will be subject to the additional tax imposed under Section 409A, and any ambiguities in this Agreement will be interpreted to so comply.
The Company and Executive agree to work together in good faith to consider amendments to this Agreement and to take such reasonable actions which are necessary, appropriate or desirable to avoid imposition of any additional tax or income recognition
under Section 409A prior to actual payment to Executive. 

(d)        Receipt of the severance payments and benefits specified in
section 8 shall be contingent on Executive’s execution of the Release, the lapse of any statutory period for revocation, and such Release becoming effective in accordance with its terms within fifty-two (52) days following the termination
date. Any severance payment to which Executive otherwise would have been entitled during such fifty-two (52) day period shall be paid by the Company in cash and in full arrears on the fifty-third (53d) day following Executive’s employment termination date or
such later date as is required to avoid the imposition of additional taxes under Section 409A. 

12.        Code Section 280G Shareholder Approval or Best Results. To the extent that
any of the payments and benefits provided for in this Agreement or otherwise payable to the Executive, including accelerated vesting of any equity compensation (collectively, the “Payments”) would (but for shareholder approval within the
meaning of Code Section 280G(b)(5)(B)) result in a “parachute payment” within the meaning of Code Section 280G (a “Parachute Payment”), the Company will use commercially reasonable efforts to solicit shareholder
approval (within the meaning of Section 280G(b)(5)(B) of the Code) of such Payments, provided; however, that if such shareholder approval is not obtained or if any stock of the Company (as determined under Section 280G of the Code
and the regulations thereunder) has become “readily tradeable on an established securities market or otherwise” within the meaning of Section 280G(b)(5)(A) of the Code, then if any Payment would (i) constitute a Parachute Payment
and (ii) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then such Payment shall be reduced to the Reduced Amount. The “Reduced Amount” shall be either
(x) the largest portion of the Payment that would result in no portion of the Payment being subject to the Excise Tax or (y) the largest portion, up to and including the total, of the Payment, whichever amount, after taking into account
all applicable federal, state and local employment taxes, income taxes, and the Excise Tax (all computed at the highest applicable marginal rate), results in Executive’s receipt, on an after-tax basis, of the greater amount of the Payment
notwithstanding that all or some portion of the Payment may be subject to the Excise Tax. If a reduction in payments or benefits constituting “parachute payments” is 

 
necessary so that the Payment equals the Reduced Amount, reduction shall occur in the following order: (A) cash payments shall be reduced first and in reverse chronological order such that
the cash payment owed on the latest date following the occurrence of the event triggering such excise tax will be the first cash payment to be reduced; (B) accelerated vesting of stock awards shall be cancelled/reduced next and in the reverse
order of the date of grant for such stock awards (i.e., the vesting of the most recently granted stock awards will be reduced first), with full-value awards reversed before any stock option or stock appreciation rights are reduced; and
(C) employee benefits shall be reduced last and in reverse chronological order such that the benefit owed on the latest date following the occurrence of the event triggering such excise tax will be the first benefit to be reduced. 

The Company shall appoint a nationally recognized accounting firm to make the determinations required hereunder and perform the foregoing
calculations. The Company shall bear all expenses with respect to the determinations by such accounting firm required to be made hereunder. 
 The accounting firm engaged to make the determinations hereunder shall provide its calculations, together with detailed supporting documentation, to the Company and Executive within fifteen
(15) calendar days after the date on which right to a Payment is triggered (if requested at that time by the Company or Executive) or such other time as requested by the Company or Executive. Any good faith determinations of the accounting firm
made hereunder shall be final, binding and conclusive upon the Company and Executive. 

13.        Written Amendment or Modification; Waiver. 

Except as provided in this paragraph, this Agreement may be altered, modified, or amended only by a writing signed by Executive and the
Company’s Chief Executive Officer expressly acknowledging that it is altering, modifying or amending the Agreement. No modification, waiver or discharge of this Agreement will be effective unless in writing signed by the Executive and by the
Company’s Chief Executive Officer or the Chairman of the Compensation Committee. No waiver by either party of any condition or provision of this Agreement shall be considered a waiver of any other condition or provision or a waiver of the same
condition or provision at another time. Notwithstanding the foregoing, the Compensation Committee may modify this Agreement unilaterally without the Executive’s written consent in the event that, in the Compensation Committee’s sole
discretion, a change in applicable laws, rules or regulations necessitate (including Code Section 409A) such modifications; however, no such modification may adversely affect any payment or benefit to the Executive under this Agreement unless
the Company provides the Executive with a substitute payment or benefit that complies with the change in legal requirements and is the economic equivalent of the adversely affected payment or benefit. 

14.        Successors and Assigns. 

This Agreement shall be binding upon Executive’s heirs, executors, administrators and other legal representatives and will be for
the benefit of the Company, its successors and assigns. This Agreement is specific to Executive and may not be assigned or substituted for without the express 

 
written consent of the Company’s Chief Executive Officer, subject to the approval of the Compensation Committee. 
 15.        Term. 
 The term of this
Agreement shall begin on the Effective Date and shall have a term of three (3) years and will automatically be renewed for one (1) year periods unless terminated by either party upon sixty (60) days written notice prior to the
expiration of the Agreement and unless otherwise terminated in accordance with the terms thereof. 

16.        Entire Agreement. 

This Agreement sets forth the entire agreement and understanding between the Company and Executive relating to its subject matter, is
fully integrated and supersedes all prior of contemporaneous discussions, representations, and agreements, whether oral or in writing, between the parties on that subject matter. 

17.        Governing Law; Consent to Personal Jurisdiction. 

This Agreement shall be governed by the laws of the State of California, without regard to the choice of law provisions thereof.
Executive hereby expressly consents to personal jurisdiction in the State and federal courts located in California for any lawsuit arising from or relating to this Agreement, without regard to her then-current residence or domicile. 

18.        Severability. 

The invalidity or unenforceability of one or more provisions of this Agreement shall not affect the validity or enforceability of any
other provision hereof, which shall remain in full force and effect to the maximum extent of the law. 
 IN WITNESS WHEREOF, each of the parties
has executed this Agreement, in the case of the Company by its duly authorized officer, as of the day and year first above written. 
  

					
	EXECUTIVE	 	UBIQUITI NETWORKS, INC.
			
	/s/ Jessica Zhou	 	By	 	/s/ Robert J. Pera
	Jessica Zhou	 		 	
		
	Dated: March 19, 2012	 	Dated: March 19, 2012

 EXHIBIT A 

UBIQUTI NETWORKS, INC./JESSICA ZHOU 
 RELEASE OF CLAIMS 
 This Release of Claims (“Agreement”) is made
by and between Ubiquiti Networks, Inc., and Jessica Zhou (“Employee”). 
 WHEREAS, Employee has agreed to enter into a
release of claims in favor of the Company upon certain events specified in the offer letter agreement by and between Company and Employee (the “Employment Agreement”). 

NOW THEREFORE, in consideration of the mutual promises made herein, the Parties hereby agree as follows: 

1.        Termination. Employee’s employment from the Company terminated on
________________ (the “Termination Date”). 
 2.        Confidential
Information. Employee shall continue to maintain the confidentiality of all confidential and proprietary information of the Company and shall continue to comply with the terms and conditions of the At-Will Employment, Confidential Information,
Invention Assignment and Arbitration Agreement (the “Confidential Information Agreement”). Employee shall return all the Company property and confidential and proprietary information in his possession to the Company on the Effective Date
of this Agreement. 
 3.        Payment of Salary. Employee acknowledges and
represents that the Company has paid all salary, wages, bonuses, accrued vacation, commissions and any and all other benefits due to Employee. 
 4.        Release of Claims. Employee agrees that the foregoing consideration represents settlement in full of all outstanding obligations owed to Employee
by the Company. Employee, on behalf of himself, and his respective heirs, family members, executors and assigns, hereby fully and forever releases the Company and its past, present and future officers, agents, directors, employees, investors,
shareholders, administrators, affiliates, divisions, subsidiaries, parents, predecessor and successor corporations, and assigns, from, and agrees not to sue or otherwise institute or cause to be instituted any legal or administrative proceedings
concerning any claim, duty, obligation or cause of action relating to any matters of any kind, whether presently known or unknown, suspected or unsuspected, that he may possess arising from any omissions, acts or facts that have occurred up until
and including the Effective Date of this Agreement including, without limitation, 

(a)        any and all claims relating to or arising from Employee’s employment relationship
with the Company and the termination of that relationship; 
 (b)        any and all
claims relating to, or arising from, Employee’s right to purchase, or actual purchase of shares of stock of the Company, including, without limitation, any claims for 

 
fraud, misrepresentation, breach of fiduciary duty, breach of duty under applicable state corporate law, and securities fraud under any state or federal law; 

(c)        any and all claims for wrongful discharge of employment; termination in violation of
public policy; discrimination; breach of contract, both express and implied; breach of a covenant of good faith and fair dealing, both express and implied; promissory estoppel; negligent or intentional infliction of emotional distress; negligent or
intentional misrepresentation; negligent or intentional interference with contract or prospective economic advantage; unfair business practices; defamation; libel; slander; negligence; personal injury; assault; battery; invasion of privacy; false
imprisonment; and conversion; 
 (d)        any and all claims for violation of any
federal, state or municipal statute, including, but not limited to, Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1991, the Age Discrimination in Employment Act of 1967, the Americans with Disabilities Act of 1990, the Fair
Labor Standards Act, the Employee Retirement Income Security Act of 1974, The Worker Adjustment and Retraining Notification Act, the California Fair Employment and Housing Act, and Labor Code section 201, et seq. and section 870, et
seq. and all amendments to each such Act as well as the regulations issued thereunder; 

(e)        any and all claims for violation of the federal, or any state, constitution;

 (f)        any and all claims arising out of any other laws and regulations relating
to employment or employment discrimination; and 
 (g)        any and all claims for
attorneys’ fees and costs. 
 Employee agrees that the release set forth in this section shall be and remain in effect in all respects as a
complete general release as to the matters released. This release does not extend to any severance obligations due or any other obligations owing to Employee under the Employment Agreement. Nothing in this Agreement waives Employee’s rights to
indemnification or any payments under any fiduciary insurance policy, if any, provided by any act or agreement of the Company, state or federal law or policy of insurance. 
 5.        Acknowledgment of Waiver of Claims under ADEA. Employee acknowledges that he is waiving and releasing any rights he may have under the Age
Discrimination in Employment Act of 1967 (“ADEA”) and that this waiver and release is knowing and voluntary. Employee and the Company agree that this waiver and release does not apply to any rights or claims that may arise under the ADEA
after the Effective Date of this Agreement. Employee acknowledges that the consideration given for this waiver and release Agreement is in addition to anything of value to which Employee was already entitled. Employee further acknowledges that he
has been advised by this writing that (a) he should consult with an attorney prior to executing this Agreement; (b) he has at least twenty-one (21) days within which to consider this Agreement; (c) he has seven
(7) days following the execution of this Agreement by the parties to revoke the Agreement; (d) this Agreement shall not be effective until the revocation period has expired; and (e) nothing in this Agreement prevents or precludes
Employee from challenging or seeking a determination in good faith of the validity of this waiver under the ADEA, nor does it impose any condition precedent, 

 
penalties or costs for doing so, unless specifically authorized by federal law. Any revocation should be in writing and delivered to the Vice-President of Human Resources at the Company by close
of business on the seventh day from the date that Employee signs this Agreement. 

6.        Civil Code Section 1542. Employee represents that he is not aware of any
claims against the Company other than the claims that are released by this Agreement. Employee acknowledges that he has been advised by legal counsel and is familiar with the provisions of California Civil Code 1542, below, which provides as
follows: 
 A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO
EXIST IN HIS FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM MUST HAVE MATERIALLY AFFECTED HIS SETTLEMENT WITH THE DEBTOR. 
 Employee, being aware of said code section, agrees to expressly waive any rights he may have thereunder, as well as under any statute or common law principles of similar effect. 

7.        No Pending or Future Lawsuits. Employee represents that he has no lawsuits,
claims, or actions pending in his name, or on behalf of any other person or entity, against the Company or any other person or entity referred to herein. Employee also represents that he does not intend to bring any claims on his own behalf or on
behalf of any other person or entity against the Company or any other person or entity referred to herein. 

8.        Application for Employment. Employee understands and agrees that, as a condition
of this Agreement, he shall not be entitled to any employment with the Company, its subsidiaries, or any successor, and he hereby waives any right, or alleged right, of employment or re-employment with the Company. 

9.        No Cooperation. Employee agrees that he will not counsel or assist any attorneys
or their clients in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints by any third party against the Company and/or any officer, director, employee, agent, representative, shareholder or
attorney of the Company, unless under a subpoena or other court order to do so. 

10.        No Admission of Liability. Employee understands and acknowledges that this
Agreement constitutes a compromise and settlement of disputed claims. No action taken by the Company, either previously or in connection with this Agreement shall be deemed or construed to be (a) an admission of the truth or falsity of any
claims heretofore made or (b) an acknowledgment or admission by the Company of any fault or liability whatsoever to the Employee or to any third party. 
 11.        Costs. The Parties shall each bear their own costs, expert fees, attorneys’ fees and other fees incurred in connection with this Agreement.

 12.        Arbitration. The Parties agree
that any and all disputes arising out of the terms of this Agreement, their interpretation, and any of the matters herein released, including any potential claims of harassment, discrimination or wrongful termination shall be subject to binding
arbitration, to the extent permitted by law, as specified in the Confidential Information Agreement. 

13.        Authority. Employee represents and warrants that he has the capacity to act on
his own behalf and on behalf of all who might claim through him to bind them to the terms and conditions of this Agreement. 

14.        No Representations. Employee represents that he has had the opportunity to
consult with an attorney, and has carefully read and understands the scope and effect of the provisions of this Agreement. Neither party has relied upon any representations or statements made by the other party hereto which are not specifically set
forth in this Agreement. 
 15.        Severability. In the event that any
provision hereof becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or void, this Agreement shall continue in full force and effect without said provision. 

16.        Entire Agreement. This Agreement, along with the Confidential Information
Agreement and Employee’s written equity compensation agreements with the Company, represents the entire agreement and understanding between the Company and Employee concerning Employee’s separation from the Company. 

17.        No Oral Modification. This Agreement may only be amended in writing signed by
Employee and the CEO of the Company or the Chair of the Board’s Compensation Committee. 

18.        Governing Law. This Agreement shall be governed by the internal substantive
laws, but not the choice of law rules, of the State of California. 

19.        Effective Date. This Agreement is effective eight (8) days after it has
been signed by both Parties. 
 20.        Counterparts. This Agreement may be
executed in counterparts, and each counterpart shall have the same force and effect as an original and shall constitute an effective, binding agreement on the part of each of the undersigned. 

21.        Voluntary Execution of Agreement. This Agreement is executed voluntarily and
without any duress or undue influence on the part or behalf of the Parties hereto, with the full intent of releasing all claims. The Parties acknowledge that: 
 (a)        They have read this Agreement; 

(b)        They have been represented in the preparation, negotiation, and execution of this
Agreement by legal counsel of their own choice or that they have voluntarily declined to seek such counsel; 

 (c)        They understand the terms and
consequences of this Agreement and of the releases it contains; 
 (d)         They are
fully aware of the legal and binding effect of this Agreement. 
 IN WITNESS THEREOF, parties hereto have executed this
Agreement on the dates set forth below. 
  

							
	EMPLOYEE	  	UBIQUITI NETWORKS, INC.
				
	By:	  	 	  	By:	  	 
				
	Date:	  	 	  	Name:	  	 
				
		  		  	Title:	  	 
				
		  		  	Date:Form Subscription Agreement

 Exhibit 10.1 
 SUBSCRIPTION AGREEMENT 
 September 28, 2012 

Insmed Incorporated 
 9 Deer Park Drive, Suite
C, 
 Monmouth Junction, New Jersey 08852 
 Ladies and Gentlemen: 
 The undersigned (the “Investor”),
hereby confirms and agrees with you as follows: 
 1. This Subscription Agreement (the “Agreement”) is
made as of the date hereof between Insmed Incorporated, a Virginia corporation (the “Company”), and the Investor. 
 2. The Company has authorized the sale and issuance to the Investor of              shares (the “Shares”) of its common
stock, par value $0.01 per share (the “Common Stock”), for a purchase price of $4.07 per share (the “Purchase Price”). 
 3. On the date hereof, the Company is offering for sale (the “Offering”) an aggregate of 6,304,102 shares of its Common Stock, at the Purchase Price, to certain investors,
including the Shares to be offered and sold to the Investor hereunder. The Company also expects to offer for sale up to an additional $2.0 million of shares of its Common Stock (based on the then most recent consolidated closing bid price of the
Common Stock on the Nasdaq Capital Market) to an investor, which offering is expected to close on or before October 31, 2012. 
 4. The offering and sale of the shares of Common Stock in the Offering are being made pursuant to (1) an effective Registration Statement on Form S-3 (Registration No. 333-182124) (the
“Registration Statement”) filed by the Company with the Securities and Exchange Commission (the “SEC”), which contains the base prospectus (the “Base Prospectus”) and was
declared effective by the SEC on July 5, 2012, (2) the free writing prospectus delivered to the Investor on the date hereof, (3) if applicable, each other “free writing prospectus” (as that term is defined in Rule 405 under
the Securities Act of 1933, as amended), that has been or will be provided to the Investor on or prior to the date hereof and (4) a final prospectus supplement (the “Prospectus Supplement” and together with the Base
Prospectus, the “Prospectus”) containing certain supplemental information regarding the Shares and terms of the Offering that will be filed with the SEC and provided to the Investor along with the Company’s counterpart
to this Agreement or made available to the Investor by the filing by the Company of an electronic version thereof with the SEC. The Registration Statement, the documents incorporated by reference therein and all free writing prospectuses provided to
or otherwise made available to Investor at the time of the Investor’s execution of this Agreement are referred to herein collectively as the “Disclosure Package.” 

5. The Company and the Investor agree that the Investor will purchase from the Company, and the Company will issue and sell to the
Investor, the number of Shares set forth below for the aggregate purchase price set forth below, pursuant to and subject to the Terms and Conditions for Purchase of Shares attached hereto as Annex I, which are incorporated herein by reference
as if fully set forth herein. Unless otherwise requested by the Investor no later than one business day after the execution of this Agreement by the Investor and agreed to by the Company, the Shares purchased by the Investor will be delivered by
electronic book-entry at The Depository Trust Company (“DTC”), registered in the Investor’s name and address as set forth below and will be released by American Stock Transfer and Trust Company, the Company’s
transfer agent (the “Transfer Agent”), to the Investor at the Closing (as defined in the Terms and Conditions for Purchase of Shares). The Investor understands and agrees that the Company, in its sole discretion, reserves the
right to accept or reject this subscription for Shares, in whole or in part. 
 6. The Investor confirms that it has had full
access to all filings made by the Company with the SEC, including the Disclosure Package (as applicable), and that it was able to read, review, download and print each such filing prior to or in connection with the receipt of this Agreement along
with the Company’s counterpart to this Agreement. On or promptly following the date hereof, the Company will file the Prospectus Supplement with the SEC containing certain supplemental information regarding the Company and the Offering.

 [Remainder of page intentionally left blank. Signature pages follow.] 

 Number of Shares:            

 Aggregate Purchase Price: $         

Please confirm that the foregoing correctly sets forth the agreement between us by signing in the space provided below for that purpose.

 Name of
Investor:                                       
              
  

			
	 By:
	 	  

		
	 Name:
	 	  

		
	 Title:
	 	  

 [Signature Page to Subscription Agreement] 

 Agreed and accepted on September 28, 2012: 

 

			
	 Insmed Incorporated

		
	 By:
	 	  

		
	 Name:
	 	  

		
	 Title:
	 	  

 [Signature Page to Subscription Agreement] 

 ANNEX I 

TERMS AND CONDITIONS FOR PURCHASE OF SHARES 
 1. Closings and Delivery of the Shares and Funds. 
 1.1.
Closing. The completion of the purchase and sale of the Shares (the “Closing”) will occur at a place and time (the “Closing Date”) to be agreed upon by the Company and the Investor. At the
Closing, the Company will cause the Transfer Agent to deliver to the Investor the number of Shares set forth on the signature page hereto registered in the name of the Investor or, if so indicated on the Investor Questionnaire attached hereto as
Exhibit A, in the name of a nominee designated by the Investor. 
 1.2. Delivery of Funds. Prior to the
Closing, the Investor shall remit by wire transfer the amount of funds equal to the aggregate purchase price for the Shares being purchased by the Investor to the following account: 

 

			
	BANK NAME:	 	
		
	BANK ADDRESS:	 	
		
	ROUTING (ABA) #:	 	
		
	SWIFT CODE:	 	
		
	CREDIT ACCOUNT:	 	
		
	ACCOUNT NAME:	 	

 1.3. Delivery of Shares. Prior to the Closing, the Investor shall direct the broker-dealer
at which the account or accounts to be credited with the Shares being purchased by such Investor are maintained, which broker/dealer shall be a DTC participant, to set up a Deposit/Withdrawal at Custodian (“DWAC”) instructing
the Transfer Agent to credit such account or accounts with the Shares by means of an electronic book-entry delivery. Such DWAC shall indicate the settlement date for the deposit of the Shares. Unless the Company and the Investor agree to an
alternative arrangement for payment of the Purchase Price for the Shares, upon receipt by the Company of the funds pursuant to Section 1.2 above, the Company shall direct the Transfer Agent to credit the Investor’s account or accounts with
the Shares pursuant to the information contained in such DWAC. 
 1.5. IT IS THE INVESTOR’S RESPONSIBILITY TO
(1) MAKE THE NECESSARY WIRE TRANSFER OR CONFIRM THE PROPER ACCOUNT BALANCE IN A TIMELY MANNER AND (2) ARRANGE FOR SETTLEMENT BY WAY OF DWAC IN A TIMELY MANNER. IF THE INVESTOR DOES NOT DELIVER THE AGGREGATE PURCHASE PRICE FOR THE SHARES OR
DOES NOT MAKE PROPER ARRANGEMENTS FOR SETTLEMENT IN A TIMELY MANNER, THE SHARES MAY NOT BE DELIVERED AT CLOSING TO THE INVESTOR. 
 2.
Representations, Warranties and Covenants of the Investor 
 2.1. The Investor represents and warrants to, and
covenants with, the Company that (a) the Investor is knowledgeable, sophisticated and experienced in making, and is qualified to make decisions with respect to, investments in shares presenting an investment decision like that involved in the
purchase of the Shares, including investments in securities issued by the Company and investments in comparable companies, and has requested, received, reviewed and considered all information it deemed relevant in making an informed decision to
purchase the Shares, (b) the Investor has answered all questions on the Signature Page and the Investor Questionnaire for use in preparation of the Prospectus Supplement and the answers thereto are true and correct as of the date hereof and
will be true and correct as of the Closing Date and (c) the Investor, in connection with its decision to purchase the number of Shares set forth on the Signature Page, has reviewed the Disclosure Package and is relying only upon the Disclosure
Package and the representations and warranties of the Company contained herein. 
 2.2. The Investor further represents
and warrants to, and covenants with, the Company that (a) the Investor has full right, power, authority and capacity to enter into this Agreement and to consummate the transactions 

 
contemplated hereby and has taken all necessary action to authorize the execution, delivery and performance of this Agreement, and (b) this Agreement constitutes a valid and binding
obligation of the Investor enforceable against the Investor in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’ and
contracting parties’ rights generally and except as enforceability may be subject to general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law). 

2.3. The Investor understands that nothing in this Agreement, the Prospectus or any other materials presented to the Investor in
connection with the purchase and sale of the Shares constitutes legal, tax or investment advice. The Investor has consulted such legal, tax and investment advisors as it, in its sole discretion, has deemed necessary or appropriate in connection with
its purchase of Shares. 
 2.4. The Investor represents, warrants and agrees that, since the earlier to occur of
(i) the date on which the Company first contacted such Investor about the Offering and (ii) the date of this Agreement, it has not engaged in any transactions in the securities of the Company in violation of securities laws (including,
without limitation, any short sales involving the Company’s securities). The Investor covenants that it will not engage in any transactions in the securities of the Company (including short sales) prior to the time that the transactions
contemplated by this Agreement are publicly disclosed. The Investor agrees that it will not use any of the Shares acquired pursuant to this Agreement to cover any short position in the Common Stock if doing so would be in violation of applicable
securities laws. For purposes hereof, “short sales” include, without limitation, all “short sales” as defined in Rule 200 promulgated under Regulation SHO under the Securities Exchange Act of 1934 (the “Exchange
Act”), whether or not against the box, and all types of direct and indirect stock pledges, forward sales contracts, options, puts, calls, short sales, swaps, “put equivalent positions” (as defined in Rule 16a-1(h) under the
Exchange Act) and similar arrangements (including on a total return basis), and sales and other transactions through non-US broker dealers or foreign regulated brokers. 
 2.5. Notwithstanding any investigation made by any party to this Agreement, all covenants, agreements, representations and warranties made by the Investor herein will survive the execution of this
Agreement, the delivery to the Investor of the Shares being purchased and the payment therefor. 
 3. Changes. This Agreement may not be
modified or amended except pursuant to an instrument in writing signed by the Company and the Investor. 
 4. Headings. The headings of
the various sections of this Agreement have been inserted for convenience of reference only and will not be deemed to be part of this Agreement. 
 5. Severability. In case any provision contained in this Agreement should be invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions
contained herein will not in any way be affected or impaired thereby. 
 6. Governing Law. This Agreement will be governed by, and
construed in accordance with, the internal laws of the State of New York, without giving effect to the principles of conflicts of law that would require the application of the laws of any other jurisdiction. 

7. Counterparts. This Agreement may be executed in two or more counterparts, each of which will constitute an original, but all of which, when
taken together, will constitute but one instrument, and will become effective when one or more counterparts have been signed by each party hereto and delivered (including by fax or electronically) to the other parties. 

 EXHIBIT A 

INSMED INCORPORATED 
 INVESTOR QUESTIONNAIRE 
 Pursuant to Section 1 of Annex I to the Agreement,
please provide us with the following information: 
  

	1.	The exact name that your Shares are to be registered in. You may use a nominee if appropriate: 

 

	2.	The relationship between the Investor and the registered holder listed in response to item 1 above (if not the same person): 

 

	3.	The mailing address of the registered holder listed in response to item 1 above: 

 

	4.	The Social Security Number or Tax Identification Number of the registered holder listed in response to item 1 above: 

 

	5.	Name of DTC Participant (broker-dealer at which the account or accounts to be credited with the Shares are maintained); please include the name and telephone number of
the contact person at the broker-dealer: 

  

	6.	DTC Participant Number: 

  

	7.	Name of Account at DTC Participant being credited with the Shares: 

  

	8.	Account Number at DTC Participant being credited with the Shares:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00208-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00208-of-00352.parquet"}]]